Correlation Engine 2.0
Clear Search sequence regions


  • cancer (1)
  • head neoplasms (1)
  • humans (1)
  • mandible (1)
  • mouth neoplasms (1)
  • neck (1)
  • neck neoplasms (1)
  • oral cancer (2)
  • patients (1)
  • segments (1)
  • signal (1)
  • swine (1)
  • titanium (1)
  • tumour (2)
  • tumour oral (1)
  • Sizes of these terms reflect their relevance to your search.

    To evaluate a novel liquid fiducial marker for intraoperative marking of the tumour resection surface in oral cancer patients to facilitate precise postoperative delineation of the interface between the tumour resection border and reconstructed tissue for intensity-modulated radiation therapy. A total of 200 markers were created by injecting the volumes of 10 µl, 20 µl, 30 µl, 40 µl and 50 µl of a liquid marker composed of sucrose acetoisobutyrate (SAIB) and iodinated sucrose acetoisobutyrate (x-SAIB) into the soft tissue of porcine mandible segments. Visibility of the resulting markers was quantified by threshold-based segmentation of the marker volume in CT- and CBCT imaging and by a comparison of signal intensities in MRI. Even the lowest volume of SAIB-/x-SAIB investigated (10 µl) resulted in a higher visibility (CTSoft tissue: 88.18 ± 13.23 µl; CTBone: 49.55 ± 7.62 µl; CBCT: 54.65 ± 12.58 µl) than observed with the incorporation of titanium ligature clips (CTSoft tissue: 50.15 ± 7.50 mm3; CTBone: 23.90 ± 3.39 mm3; CBCT: 33.80 ± 9.20 mm3). Markers created by the injection of 10 µl and 20 µl could reliably be delineated from markers created by the injection of higher volumes. SAIB/x-SAIB, which has recently become available as a Conformité Européenne (CE)-marked fiducial marker, provides an option for fast and reliable production of markers with excellent visibility in imaging modalities used in oral cancer radiation therapy (RT) planning routine.

    Citation

    David Steybe, Maximilian Frederik Russe, Ute Ludwig, Tanja Sprave, Kirstin Vach, Wiebke Semper-Hogg, Rainer Schmelzeisen, Pit Jacob Voss, Philipp Poxleitner. Intraoperative marking of the tumour resection surface for improved radiation therapy planning in head and neck cancer: preclinical evaluation of a novel liquid fiducial marker. Dento maxillo facial radiology. 2021 Mar 01;50(3):20200290

    Expand section icon Mesh Tags


    PMID: 32915672

    View Full Text